Global Coronavirus (COVID-19) Current Therapy Market To Grow At Rate Of 52.5% Through 2020

(ABNewswire via Comtex)

The global COVID-19 current therapy market is expected to grow from $10.83 billion in 2019 to $16.51 billion in 2020 at a compound annual growth rate (CAGR) of 52.5%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. With no effective therapeutics discovered so far, existing drugs such as Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, among others are being repurposed for the COVID-19 treatment. The market is then expected to stabilize and reach $27.27 billion in 2023 at a CAGR of 18.2%.

Read More On The Global Coronavirus (COVID-19) Current Therapy Market Report At -

https://www.thebusinessresearchcompany.com/report/coronavirus-covid-19-current-therapy-market-global-report-2020-covid-19-growth-and-change

The coronavirus (COVID-19) current therapy market consists of sales of drugs currently used for the treatment of COVID-19 infection. The market report includes single-drug therapeutics and combination drug therapeutics used in treating COVID-19 patients. The market consists of revenue generated by the companies that manufacture coronavirus current therapeutics by the sales of these products.

Global Coronavirus (COVID-19) Current Therapy Market Segmentation –

The COVID-19 current therapy market covered in this report is segmented
By Drug Type: Antiviral (Remdesivir, Ritonavir, Lopinavir), Antimalarial (Hydroxychloroquine), Interferons (Interferon Beta), Corticosteroid (Dexamethasone), Others
By End-Use: Hospitals, Clinics, Research Institutes, Others.

Global Coronavirus (COVID-19) Current Therapy Market Trends –

Convalescent Plasma Therapy is used as an experimental therapy to treat COVID-19 patients. The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent Plasma (CP) therapy is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to the patient with severe disease to suppress the virulence and improve clinical symptoms. The blood plasma of recovered COVID-19 patients has antibodies to fight COVID-19 infection.

Request For A Sample Of The Global Coronavirus (COVID-19) Current Therapy Market Report At -

https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

A Few Points From The Global Coronavirus (COVID-19) Current Therapy Market ToC
1. Executive Summary
2. Coronavirus (COVID-19) Current Therapy Market Characteristics
3. Coronavirus (COVID-19) Current Therapy Market Size And Growth
3.1. Global Coronavirus (COVID-19) Current Therapy Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Coronavirus (COVID-19) Current Therapy Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Coronavirus (COVID-19) Current Therapy Market Segmentation
5. Coronavirus (COVID-19) Current Therapy Market Regional And Country Analysis
5.1. Global Coronavirus (COVID-19) Current Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Coronavirus (COVID-19) Current Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/



comtex tracking